Antiplatelet therapy reduces atherothrombotic risk and has therefore become a cornerstone
in the treatment of cardiovascular disease. Aspirin, adenosine diphosphate P2Y12 receptor …

Platelets have a crucial role in haemostasis and atherothrombosis. Pharmacological control
of platelet hyper-reactivity has become a cornerstone in the prevention of thrombo …

Antiplatelet therapy is a cornerstone in the secondary prophylaxis of adverse cardiovascular
events such as myocardial infarction and stroke. The cyclooxygenase inhibitor aspirin …

Thrombosis, both venous and arterial, is a major cause of morbidity and mortality worldwide.
Consequently, there is an ongoing search for new antithrombotic drugs, particularly novel …

Antiplatelet therapy plays a critical role in the prevention and treatment of major
cardiovascular diseases triggered by thrombosis. Since the 1900s, significant progress in …

Antiplatelet therapy is the cornerstone of treatment for patients with acute coronary
syndrome (ACS) or undergoing percutaneous coronary intervention (PCI). Despite the use …

Antiplatelet therapy Page 1 Hospital Medicine, January 2000, Vol 61, No 1 15 Platelet-initiated
thrombus plays a cen- tral role in the pathogenesis of coronary artery disease, especially in the …

Platelets are the key in the pathogenesis of atherothrombotic disease such as acute
coronary syndromes, stroke, and peripheral arterial disease. Current anti-platelet treatments …

Thrombosis, the localized clotting of blood that affects arterial or venous circulation, is one of
the leading causes of death worldwide. Arterial thrombosis is commonly initiated by vascular …

Platelet activation is a complex mechanism of response to vascular injury and
atherothrombotic disease, leading to thrombus formation. A wide variety of surface receptors …